Atlas Trials

A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia

Clinical trial NCT00594555 · WITHDRAWN

Trial details

NCT number
NCT00594555
Sponsor
University of Cincinnati
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia, Blast CrisisAcute Myeloid Leukemia
Start date
2007-11-01
Primary completion
2008-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.